Announcement on Election of Employee Director
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
The company held a shareholder meeting to revise its articles of association and approved the election of Wang Xiangfen as the employee representative director.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on Attending Three-Quarter Report Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025
- Announcement on Progress in Public Listing and Transfer of Equity in a Holding Subsidiary and Completing Industrial and Commercial Change
- Report for Q3 2025
- Announcement on Prospective Winning of the 11th National Centralized Drug Procurement
- Announcement on the Progress and Transaction Results of the Public Listing Transfer of Subsidiary Equity
Later from Shanghai Shyndec Pharmaceutical
- Notice on Convening the 3rd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 1st Meeting of the 9th Board of Directors
- Announcement on Provision for Impairment
- Announcement on Wholly-owned Subsidiary's Passing GMP Compliance Inspection for Drugs
- Announcement on Proposed Selection of Partial Drugs for Continuation Procurement Under National Procurement Scheme After Agreement Expiry
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical